回复：在成年囊性纤维化患者中，使用依列卡福/替扎卡福/依伐卡福可逆转结构异常：越早开始治疗，效果越好！ - Suppr

Reply: Reversal of structural abnormalities with elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis: the earlier you start, the better the outcome will be!

作者信息

Chassagnon Guillaume, Burgel Pierre-Régis

机构信息

Service de Radiologie A, Radiology Department, Cochin Hospital, Broca Hôtel-Dieu, Assistance Publique Hôpitaux de Paris, Paris, France.

Université Paris Cité, Paris, France.

出版信息

Eur Respir J. 2024 Sep 26;64(3). doi: 10.1183/13993003.01247-2024. Print 2024 Sep.

DOI:10.1183/13993003.01247-2024

PMID:39326907

Abstract

摘要

相似文献

Reply: Reversal of structural abnormalities with elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis: the earlier you start, the better the outcome will be!

Eur Respir J. 2024 Sep 26;64(3). doi: 10.1183/13993003.01247-2024. Print 2024 Sep.

Reversal of cystic bronchiectasis with elexacaftor/tezacaftor/ivacaftor.

Eur Respir J. 2024 Sep 26;64(3). doi: 10.1183/13993003.00929-2024. Print 2024 Sep.

Elexacaftor/Tezacaftor/Ivacaftor therapy in cystic fibrosis children previously CFSPID: Is it over-medicalization?

J Cyst Fibros. 2024 Mar;23(2):366-367. doi: 10.1016/j.jcf.2023.10.008. Epub 2023 Oct 13.

Elexacaftor/Tezacaftor/Ivacaftor Effectiveness in N1303K Variant in Adult People With Cystic Fibrosis.

Arch Bronconeumol. 2024 Aug;60(8):526-528. doi: 10.1016/j.arbres.2024.04.007. Epub 2024 Apr 24.

Clinical effectiveness of elexacaftor/tezacaftor/ivacaftor in a man with A559T and 3120+1G>CFTR variants.

Pediatr Pulmonol. 2024 Jul;59(7):2009-2011. doi: 10.1002/ppul.26997. Epub 2024 Apr 12.

Reply to Piehler : Depression Symptoms in Patients with Cystic Fibrosis Fluctuate at Baseline and Improve with Elexacaftor/Tezacaftor/Ivacaftor Therapy.

Am J Respir Crit Care Med. 2024 Aug 1;210(3):367. doi: 10.1164/rccm.202404-0852LE.

Efficacy of elexacaftor-tezacaftor-ivacaftor in portuguese adolescents and adults with cystic fibrosis carrying non-F508del variants.

Pulmonology. 2024 Sep-Oct;30(5):485-487. doi: 10.1016/j.pulmoe.2024.03.001. Epub 2024 Apr 13.

The expanded French compassionate programme for elexacaftor-tezacaftor-ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study.

Lancet Respir Med. 2024 Nov;12(11):888-900. doi: 10.1016/S2213-2600(24)00208-X. Epub 2024 Aug 13.

Case report of two adults with F508del/3849+10 kb C > T genotype regaining exocrine pancreatic function following treatment with elexacaftor/tezacaftor/ivacaftor.

J Cyst Fibros. 2024 Jul;23(4):744-745. doi: 10.1016/j.jcf.2023.12.001. Epub 2023 Dec 14.

Patients eligible for modulator drugs: Data from cystic fibrosis registry of Turkey.

Pediatr Pulmonol. 2020 Sep;55(9):2302-2306. doi: 10.1002/ppul.24854. Epub 2020 May 26.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Reply: Reversal of structural abnormalities with elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis: the earlier you start, the better the outcome will be!

Eur Respir J. 2024 Sep 26;64(3). doi: 10.1183/13993003.01247-2024. Print 2024 Sep.

Reversal of cystic bronchiectasis with elexacaftor/tezacaftor/ivacaftor.

Eur Respir J. 2024 Sep 26;64(3). doi: 10.1183/13993003.00929-2024. Print 2024 Sep.

Elexacaftor/Tezacaftor/Ivacaftor therapy in cystic fibrosis children previously CFSPID: Is it over-medicalization?

J Cyst Fibros. 2024 Mar;23(2):366-367. doi: 10.1016/j.jcf.2023.10.008. Epub 2023 Oct 13.

Elexacaftor/Tezacaftor/Ivacaftor Effectiveness in N1303K Variant in Adult People With Cystic Fibrosis.

Arch Bronconeumol. 2024 Aug;60(8):526-528. doi: 10.1016/j.arbres.2024.04.007. Epub 2024 Apr 24.

Clinical effectiveness of elexacaftor/tezacaftor/ivacaftor in a man with A559T and 3120+1G>CFTR variants.

Pediatr Pulmonol. 2024 Jul;59(7):2009-2011. doi: 10.1002/ppul.26997. Epub 2024 Apr 12.

Reply to Piehler : Depression Symptoms in Patients with Cystic Fibrosis Fluctuate at Baseline and Improve with Elexacaftor/Tezacaftor/Ivacaftor Therapy.

Am J Respir Crit Care Med. 2024 Aug 1;210(3):367. doi: 10.1164/rccm.202404-0852LE.

Efficacy of elexacaftor-tezacaftor-ivacaftor in portuguese adolescents and adults with cystic fibrosis carrying non-F508del variants.

Pulmonology. 2024 Sep-Oct;30(5):485-487. doi: 10.1016/j.pulmoe.2024.03.001. Epub 2024 Apr 13.

The expanded French compassionate programme for elexacaftor-tezacaftor-ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study.

Lancet Respir Med. 2024 Nov;12(11):888-900. doi: 10.1016/S2213-2600(24)00208-X. Epub 2024 Aug 13.

Case report of two adults with F508del/3849+10 kb C > T genotype regaining exocrine pancreatic function following treatment with elexacaftor/tezacaftor/ivacaftor.

J Cyst Fibros. 2024 Jul;23(4):744-745. doi: 10.1016/j.jcf.2023.12.001. Epub 2023 Dec 14.

Patients eligible for modulator drugs: Data from cystic fibrosis registry of Turkey.

Pediatr Pulmonol. 2020 Sep;55(9):2302-2306. doi: 10.1002/ppul.24854. Epub 2020 May 26.

Reply: Reversal of structural abnormalities with elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis: the earlier you start, the better the outcome will be!

作者信息

Chassagnon Guillaume, Burgel Pierre-Régis

机构信息

Service de Radiologie A, Radiology Department, Cochin Hospital, Broca Hôtel-Dieu, Assistance Publique Hôpitaux de Paris, Paris, France.

Université Paris Cité, Paris, France.

出版信息

Eur Respir J. 2024 Sep 26;64(3). doi: 10.1183/13993003.01247-2024. Print 2024 Sep.

DOI:10.1183/13993003.01247-2024

PMID:39326907

Abstract

摘要

Reply: Reversal of structural abnormalities with elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis: the earlier you start, the better the outcome will be!

作者信息

机构信息

出版信息

相似文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

Reply: Reversal of structural abnormalities with elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis: the earlier you start, the better the outcome will be!

作者信息

机构信息

出版信息